🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Healthkart’s revenue nears Rs 1,400 Cr in FY25; profit triples

EntrackrEntrackr · 1m ago
Healthkart’s revenue nears Rs 1,400 Cr in FY25; profit triples
Medial

Healthkart’s revenue nears Rs 1,400 Cr in FY25; profit triples HealthKart, a nutrition and supplement e-commerce platform, recorded a 3X year-on-year jump in profit after turning profitable in FY24. The Gurugram-based company’s sharp profit growth was steered by strong sales momentum and a controlled cost structure. Healthkart’s operating revenue grew 29% to Rs 1,313 crore in FY25 from Rs 1,021 crore in FY24, according to its consolidated financial statement sourced from the Registrar of Companies (RoC). HealthKart owns and manufactures eight nutritional brands including popular supplement brands like MuscleBlaze, The Protein Zone, TrueBasics, HKVitals, bGreen, Nouriza, and Gritzo. Sales of products formed 97% of total revenue which rose by 29% to Rs 1,277 crore in FY25. Collections from services also increased by 16% to Rs 36 crore. Notably, non-operating revenue increased to Rs 55 crore in the last fiscal year from Rs 48 crore in FY24. The cost of materials accounted for the largest share of the company’s expenditure at 49%. To the tune of scale, this cost rose 26% to Rs 623 crore in FY25 from Rs 495 crore in FY25. Advertising spend saw a sharper rise of 39% to Rs 263 crore, while commission expenses increased 22% to Rs 82 crore. In contrast, employee benefit costs declined 5% to Rs 115 crore. Overall, Healthkart managed to keep its cost growth below revenue expansion. Its total expenses rose 23% to Rs 1,273 crore in FY25 from Rs 1,032 crore in FY24. The company’s profit surged over 3X to Rs 120 crore in FY25, while its ROCE and EBITDA margin improved to 5.45% and 6.02%, respectively. On a unit basis, Healthkart spent Re 0.97 to earn a rupee of operating revenue in FY25, compared to Rs 1.01 in FY24. As of FY25, its current assets stood at Rs 971 crore including Rs 73 crore in cash and bank balances. According to startup data intelligence platform TheKredible, Healthkart has raised a total of $382 million of funding till date, having Peak XV Partners, Temasek and Sofina as its lead investors. The company’s founder and CEO, Sameer Maheshwari owns 12% of the company.

Related News

PB Fintech crosses Rs 1,508 Cr revenue in Q4 FY25; profit triples

EntrackrEntrackr · 7m ago
PB Fintech crosses Rs 1,508 Cr revenue in Q4 FY25; profit triples
Medial

PB Fintech, the parent company of online insurance aggregator and brokerage platform PolicyBazaar, has released its financial results for the fourth quarter of the ongoing fiscal year (Q4 FY25). The company reported a 38% growth in scale, while its year-on-year (YoY) profits increased by 2.85X during the same period. PolicyBazaar’s revenue from operations surged 38% to Rs 1,508 crore in Q4 FY25 in contrast to Rs 1,089 crore in Q4 FY24, as per the firm’s consolidated financial results sourced from the National Stock Exchange (NSE). For the full fiscal year (FY25), PolicyBazaar’s operating revenue increased 33% to Rs 4,977 crore in FY25 from Rs 3,738 crore in FY24. The Gurugram-based company generated the largest share (87%) of its operating revenue from insurance broker services, which rose to Rs 1,322 crore in Q4 FY25 from Rs 915 crore in Q4 FY24. For the full fiscal year, it accounted for 86% of the revenue at Rs 4,298 crore. Besides operating revenue, the firm also earned Rs 101 crore via interest and gains from financial assets during the quarter which took its total topline to Rs 1,609 crore in the quarter ending March 2025. Meanwhile, for the full fiscal year, total income crossed the Rs 5,000 crore mark at Rs 5,385 crore. PolicyBazaar has not provided a detailed breakdown of expenses in its quarterly financial statements. However, employee benefits expenses rose by 15% YoY to Rs 508 crore. Overall, the company's total costs grew 29% to Rs 1,437 crore in Q4 FY25 compared to Rs 1,114 crore in Q4 FY24. For the full financial year ending March 2025, the firm’s total expenses rose to Rs 5,039 crore as against Rs 3,739 crore in FY24. In the end, PolicyBazaar's net profits surged 2.85X to Rs 171 crore in Q4 FY25 from Rs 60 crore in Q4 FY24. On a fiscal basis, its net profit spiked 5.5X to Rs 353 crore in FY25 from Rs 64 crore in FY24. PolicyBazaar is currently trading at Rs 1,796 with a total market capitalization of Rs 82,500 crore.

Gameskraft crosses Rs 4,000 Cr revenue in FY25; PAT nears Rs 1,000 Cr

EntrackrEntrackr · 3m ago
Gameskraft crosses Rs 4,000 Cr revenue in FY25; PAT nears Rs 1,000 Cr
Medial

Gameskraft crosses Rs 4,000 Cr revenue in FY25; PAT nears Rs 1,000 Cr Gameskraft’s FY25 numbers reflect strong performance before the RMG ban. The firm reported double-digit revenue growth and maintained profitability during the fiscal year. The Indian government’s recent ban on real-money gaming formats has disrupted the sector overnight, but Gameskraft’s FY25 numbers reflect strong performance before the clampdown. The firm reported double-digit revenue growth and maintained profitability during the fiscal year. Gameskraft’s revenue from operations grew 12% to Rs 3,896 crore in FY25 from Rs 3,475 crore in FY24, according to its consolidated financial statements sourced from the Registrar of Companies (RoC). Gameskraft operated popular gaming apps such as Rummy Culture, Playship, Pocket 52, RummyPrime, Ludo Culture, and Rummy Time. Its revenue (gross gaming revenue) came from platform fee or commission charged as a percentage of the buy-in fees users invest in games, which contributed Rs 3,882 crore (99.6% of operating revenue), registering a 12.2% growth. Its real estate business added Rs 11 crore, while other income sources contributed Rs 3 crore in FY25. The Bengaluru-based company made an additional Rs 113 crore from non-operating sources which pushed its total revenue to Rs 4,009 crore in FY25. On the cost side, promotional spending emerged as the single largest expense and accounted for 75% of total burn. To the tune of scale, this cost surged 58% to Rs 2,072 crore in FY25 from Rs 1,315 crore in FY24. Employee benefits, on the other hand, saw a decline of 11% to Rs 410 crore, while legal and professional fees fell 22.8% to Rs 112 crore in FY25. Overall, the company’s total expenses shot up 24% to Rs 2,766 crore in FY25 as against Rs 2,232 crore in FY24. See TheKredible for the detailed cost breakdown during the last fiscal year. Despite the jump in ad spend, Gameskraft managed to sustain profitability on the back of its strong topline and controlled costs in other areas. Its net profit stood at Rs 976 crore in FY25, slightly higher than the Rs 947 crore posted in FY24. It's worth noting that we have excluded exceptional items worth Rs 270.5 crore in the calculation of net profit of the company. Gameskraft's ROCE and EBITDA margin stood at 58.40% and 31.63%, respectively. On a unit basis, Gameskraft spent Rs 0.71 to earn a rupee of operating revenue in FY25. The company recorded current assets worth Rs 2,232 crore in FY25 which includes Rs 253 crore in cash and bank balances and Rs 1,319 crore invested in mutual funds. While Gameskraft’s FY25 numbers were unaffected, the Indian government’s new gaming law effective August 2025 has forced the company to halt its real-money operations, including shutting down “Add Cash” features and discontinuing its flagship rummy platform RummyCulture, alongside pausing its poker venture Pocket52 earlier in the year. The move, mandated by the Promotion and Regulation of Online Gaming Act, has also led Gameskraft to publicly state it will not pursue a legal challenge, instead opting for full compliance. Given that real-money gaming contributed nearly all of Gameskraft’s FY25 revenue, the ban is expected to significantly impact its business model, revenue streams, and growth trajectory going forward.

Healthians posts Rs 263 Cr revenue in FY25; nears breakeven

EntrackrEntrackr · 1m ago
Healthians posts Rs 263 Cr revenue in FY25; nears breakeven
Medial

Healthians posts Rs 263 Cr revenue in FY25; nears breakeven Healthians didn't manage notable growth in the fiscal year ending March 2025. However, the WestBridge-backed company narrowed its losses by 89% year on year and neared break-even during the same period. The firm’s operating revenue increased 8% year-on-year to Rs 263 crore in FY25, up from Rs 243 crore in FY24, as per its consolidated financial statements filed with the Registrar of Companies (RoC). Including non-operating income of Rs 7 crore, the company’s total income grew 7% to Rs 270 crore during the year. Cost optimisation played a key role in supporting the company’s financial recovery. Total expenses declined 8% to Rs 275 crore in FY25, compared to Rs 298 crore last year. Among the major cost heads, employee benefits, the largest expense category, dropped 13% year-on-year to Rs 104 crore in FY25 from Rs 120 crore in FY24. Cost of materials contracted 7% to Rs 54 crore. Advertising costs rose 10% to Rs 43 crore. Meanwhile, depreciation and finance costs remained stable at Rs 29 crore and Rs 15 crore, respectively. The improvement in revenue and control of key expenses helped Healthians bring down its losses sharply by 89% to Rs 5 crore in FY25 from Rs 45 crore in FY24. The firm posted positive EBITDA of Rs 32 crore in FY25 with EBITDA margin of 12.17%. Its ROCE stood at 2.73% in the same period. On a unit basis, the company spent Rs 1.05 to earn a rupee of operating revenue in FY25. The firm’s current assets increased slightly to Rs 170 crore including cash and bank balances worth Rs 49 crore in the fiscal. According to startup data intelligence platform TheKredible, Healthians has raised a total of $75 million of funding till date, having WestBridge, BEENEXT, DG Ventures and Youwecan as its lead investors. The company’s founder and CEO, Deepak Sahni owns 6.5% of the company.

JM Financial initiates buy rating on TBO Tek; estimates Rs 465 Cr revenue in Q4 FY25

EntrackrEntrackr · 8m ago
JM Financial initiates buy rating on TBO Tek; estimates Rs 465 Cr revenue in Q4 FY25
Medial

JM Financial initiates buy rating on TBO Tek; estimates Rs 465 Cr revenue in Q4 FY25 JM Financial Institutional Securities has reiterated its Buy rating on TBO Tek, setting a target price of Rs 1,400. This implies a potential upside of 31.5% from the current market price of Rs 1,065 per share. According to JM Financial, TBO Tek’s revenue from operations will see a 25.8% year-on-year growth to Rs 464.5 crore in Q4 FY25, compared to Rs 369.1 crore in the same quarter the previous fiscal year (Q4 FY24). Revenue from hotel and package bookings is expected to contribute 78.7% of TBO’s total income, rising 34.6% year-on-year to Rs 365.9 crore in Q4 FY25 from Rs 271.8 crore in Q3 FY24. Meanwhile, income from air ticketing and other allied services is projected to add Rs 86.9 crore and Rs 11.6 crore, respectively, to the company’s topline. TBO’s gross profit margin is projected to rise to 70.3% in Q4 FY25, up from 68% in Q4 FY24. Moreover, its profit after tax is expected to see a modest year-on-year growth of 1.28%, reaching Rs 47.2 crore in Q4 FY25, compared to Rs 46.6 crore in the same quarter last year. On a sequential basis, the company is expected to end the previous fiscal year (FY25) with a revenue of Rs 1755.8 crore and a profit of Rs 214.5 crore. TBO Tek ended the day at Rs 1,065.5 on April 8, with a market capitalization of Rs 11,570 crore (approximately $1.36 billion). Notably, the stock had touched its 52-week low just a day earlier, on April 7, 2025.

Tata 1mg revenue nears Rs 2,400 Cr in FY25, trims losses

EntrackrEntrackr · 5m ago
Tata 1mg revenue nears Rs 2,400 Cr in FY25, trims losses
Medial

Tata 1mg, the digital healthcare platform backed by Tata Digital, continued its growth trajectory in the fiscal year ending March 2025 while straining its losses. Tata 1mg’s consolidated revenue rose 22% to Rs 2,392 crore in FY25 from Rs 1,968 crore in FY24, according to Tata Sons’ Annual Report for the fiscal year. Tata 1mg is a health tech startup for online orders of allopathic, ayurvedic, homeopathic medicines, vitamins, nutrition supplements, and other health products, delivered to the home. 1mg’s revenue was split across two entities: Tata 1mg Technologies, which clocked Rs 2,016.5 crore, and Tata 1mg Healthcare Solutions, which contributed Rs 375.5 crore in FY25. The company's total cost rose by 17% to Rs 2682 crore in FY25, up from Rs 2303 crore in FY24. The Gurugram-based company posted a consolidated loss of Rs 276 crore in FY25, 12% lower than the Rs 313 crore loss reported in FY24. On a unit basis, the company spent Rs 1.12 to earn a rupee of operating revenue in FY25. On the asset side, Tata 1mg reported total assets of Rs 2,025 crore at the end of FY25 while its total liabilities reached Rs 1,190 crore. In the e-health space, Tata 1mg competes with Reliance-backed Netmeds, PharmEasy, and Apollo 24/7. Tata Digital acquired a 55% stake in 1mg in June 2021 but has since gained around 8.5% additional stake in the e-medicine platform. According to TheKredible, Tata Digital currently holds a 63.5% stake in 1mg, which was last valued at 1.25 billion. Tata Digital reported a standalone revenue of Rs 546.9 crore and a loss of Rs 827.5 crore in FY25, indicating continued investment in its digital commerce bets including 1mg and other verticals such as BigBasket, Cult.fit, and the recently launched Tata Neu.

Decathlon India reports Rs 65 Cr loss in FY25 as compared to Rs 197 Cr PAT in FY24

EntrackrEntrackr · 7d ago
Decathlon India reports Rs 65 Cr loss in FY25 as compared to Rs 197 Cr PAT in FY24
Medial

Decathlon, the French sporting goods retailer’s Indian arm, reported a net loss of Rs 65 crore in the fiscal year ending March 2025, compared to a profit of Rs 197 crore in FY24. The reversal came as a sharp rise in operating expenses seconded revenue growth during the year. Decathlon’s revenue from operations grew by 3% year-on-year to Rs 4,133 crore in FY25 from Rs 4,008 crore in FY24, according to its financial report sourced from Registrar of Companies (RoC). Including other income of Rs 49 crore, the company’s total income stood at Rs 4,182 crore in FY25, compared to Rs 4,067 crore a year earlier. On the spending side, the cost of materials, which includes sourcing and procurement of sporting goods, remained the largest expense, accounting for 62% of the total expense. This cost rose 8% to Rs 2,644 crore in FY25 from Rs 2,457 crore in FY24. Employee benefit expenses grew 11% to Rs 363 crore, while depreciation costs surged 74.3% to Rs 305 crore during the last fiscal year. Other expenses, including store operations and overheads, increased 13.7% year-on-year to Rs 952.5 crore. Overall, the company’s total expense rose 12.3% to Rs 4,264.5 in FY25 from Rs 3,797 crore in FY24. With the company’s expense outpacing revenue growth, it recorded a net loss of Rs 65 crore in FY25, as compared to a profit of Rs 197 crore in FY24. However, the company reported positive EBITDA of Rs 174 crore in the same period. Its ROCE and EBITDA margin stood at -5.73% and 4.20%, respectively. On a unit basis, the company spent Rs 1.03 to earn a rupee of operating revenue in FY25. On the balance sheet front, its current assets increased to Rs 1,400 crore from Rs 1,247 crore, while cash and bank balances declined sharply to Rs 73 crore at the end of FY25 from Rs 320 crore a year earlier.

Foxtale’s revenue nears Rs 200 Cr in FY25; losses jump 38%

EntrackrEntrackr · 1d ago
Foxtale’s revenue nears Rs 200 Cr in FY25; losses jump 38%
Medial

Foxtale, a direct-to-consumer skincare and beauty brand, continued its strong growth momentum in FY25 as it scaled up aggressively. However, the Mumbai-based company remained in the red due to a sharp rise in expenses. Foxtale’s revenue from operations grew 2.4x to Rs 199 crore in FY25 from Rs 83 crore in FY24, according to its financial statements filed with the Registrar of Companies (RoC). Founded in 2021 by Romita Mazumdar, Foxtale is an affordable skincare brand focused on products designed for Indian skin. Its products target issues such as acne, aging, and hyperpigmentation. The sale of skin and beauty products was Foxtale's sole source of revenue in the fiscal year. Including other income of Rs 7 crore, the company’s total income stood at Rs 206 crore during FY25. On the spending side, advertising cost accounted for 38% of the total expense. To the tune of scale, this cost more than doubled to Rs 106 crore in FY25 from Rs 50 crore in FY24. Cost of material also doubled to Rs 74 crore in FY25 from Rs 34 crore in FY24. Employee benefit expense increased by 55% to Rs 31 crore in the same period. Overall, Foxtale’s total expenses more than doubled to Rs 279 crore in FY25 from Rs 139 crore in FY24. The company’s net loss increased by 38% to Rs 73 crore in FY25 from Rs 55 crore in FY24. Its ROCE and EBITDA margin improved to -26.87% and -39.20% respectively. On a unit basis, Foxtale spent Rs 1.40 to earn a rupee of operating revenue in FY25, improving from Rs 1.67 in the previous fiscal year. Its cash and bank balance increased to Rs 166 crore in FY25 from Rs 43 crore in FY24, while current assets grew to Rs 316 crore. According to TheKredible, Foxtale has raised a total of $52 million of funding till date, having Matrix Partners and Kae Capital as its lead investors. The company’s Founder and CEO, Romita Mazumdar owns 34% of the company. Foxtale recently said that about 50% of purchases through its D2C website are from repeat customers. It also claimed that it is on track to end the year with an Annual Recurring Revenue (ARR) of over Rs 700 crore in GMV and expects to achieve profitability next year.

Mosaic Wellness revenue doubles to Rs 736 Cr in FY25, nears break-even

EntrackrEntrackr · 1m ago
Mosaic Wellness revenue doubles to Rs 736 Cr in FY25, nears break-even
Medial

Mosaic Wellness revenue doubles to Rs 736 Cr in FY25, nears break-even Mosaic Wellness, the parent company of digital-first health and wellness brands Man Matters and Bodywise, continued its growth trajectory in FY25, more than doubling its scale while significantly narrowing its losses in the fiscal year ending March 2025. The company’s operating revenue spiked 2.2X to Rs 736 crore in FY25 from Rs 333 crore in FY24, according to its consolidated financial statements sourced from the Registrar of Companies (RoC). Mosaic Wellness is a digital-first consumer health platform that runs separate brands for men, women, and kids. Its flagship brand ManMatters offers solutions across derma, sexual health, hygiene, and nutrition. The company has not disclosed the revenue from its brands separately but the sale of health and wellness products was the only source of income for Mosaic Wellness in FY25. It also added Rs 13 crore from the interest on deposits and gain on sale on investments which brought its total revenue to Rs 749 crore in the last fiscal year. The company’s advertising expense remained its largest cost centre, accounting for 35% of the total spend. This cost nearly doubled to Rs 267 crore in FY25 from Rs 138 crore. The cost of materials also grew sharply to Rs 193 crore, forming over 25% of the expenditure. Meanwhile, the company’s employee benefit expense remained stable at Rs 63 crore in FY25. Overall, Mosaic Wellness’ total expense doubled to Rs 758 crore in FY25 from Rs 380 crore in FY24. With the company’s revenue outpacing expense growth, the company managed to bring down its net loss by 69%, narrowing it to Rs 12 crore in FY25 from Rs 39 crore in FY24. Its ROCE and EBITDA margin stood at -6.55% and -2.79%, respectively. Mosaic Wellness spent Rs 1.03 to earn a rupee of operating revenue in FY25, an improvement from Rs 1.14 in the previous year. The firm closed the fiscal with Rs 49 crore in cash and bank balances, while its current assets nearly doubled to Rs 325 crore. According to TheKredible, the company has raised a total of $63 million of funding till date, having Elevation Capital, Peak XV Partners and Matrix Partners as its lead investors. The company’s co-founders Revant Bhate and Dhyanesh Shah own around 35% of the company.

Cashify’s FY25 income nears Rs 1,100 Cr, losses shrink 80%

EntrackrEntrackr · 2m ago
Cashify’s FY25 income nears Rs 1,100 Cr, losses shrink 80%
Medial

Cashify’s FY25 income nears Rs 1,100 Cr, losses shrink 80% Cashify has demonstrated stellar financial performance in the fiscal year ending March 2025. While it reported a 17% rise in revenue, surpassing the Rs 1,000 crore threshold, the Gurugram-based firm also narrowed losses by 80% during FY25. Cashify’s operational revenue reached Rs 1,096 crore in FY25 from Rs 935.07 crore in FY24, the company’s consolidated annual financial statements sourced from the Registrar of Companies (RoC) show. Cashify allows users to buy and sell used electronics, focusing mainly on phones and laptops. The company partners with original equipment manufacturers such as Xiaomi, OnePlus, and Samsung to run exchange programs. The firm also works with e-commerce giants Amazon and Flipkart to streamline the trade of refurbished devices for customers. Sales of pre-owned devices contributed Rs 999 crore which grew 17% year-on-year during the last fiscal year. Revenue from services such as repairs and commissions grew 22% to Rs 97 crore. Other income, including interest on deposits, added Rs 26 crore to total income, which stood at Rs 1,12 crore for FY25. Cashify’s expenses increased by 12% to Rs 1,133 crore in FY25 against Rs 1,008 crore in FY24. The largest expense was the cost of material which accounted for 82% of the total cost, this expense rose by 15% to Rs 924 crore. Employee benefits cost remained almost unchanged at Rs 122 crore. Other overheads including selling, distribution, advertising, and miscellaneous expenses added another Rs 44 crore to the total expenditure. With revenue outpacing expenses, Cashify managed to narrow its losses by a whopping 80%, to Rs 10.5 crore in FY25 from Rs 53 crore in FY24. The company’s EBITDA margin was negative at -2.14%, and return on capital employed stood at -10.28% in the last fiscal year. As of March 2025, Cashify’s cash and cash equivalents stood at Rs 68 crore, which decreased by 25% from last year’s Rs 91 crore. Its current assets stood at Rs 424 crore in FY25, as compared to Rs 383 crore in FY24. While the firm ended the last fiscal year with a loss, co-founder Mandeep Manocha recently said that it expects to achieve full-year profitability by the end of the ongoing fiscal year (FY26). Cashify has raised $130 million across multiple funding rounds. According to TheKredible, NewQuest Capital is the largest external shareholder with a 19.5% stake, followed by Olympus and MIH Ecommerce Holdings. It competes with several players in the market including Greendust, InstaCash, and Yaantra.

Delhivery reports Rs 70 Cr profit in Q4 FY25; revenue jumps 6%

EntrackrEntrackr · 7m ago
Delhivery reports Rs 70 Cr profit in Q4 FY25; revenue jumps 6%
Medial

Delhivery reports Rs 70 Cr profit in Q4 FY25; revenue jumps 6% Logistics company Delhivery announced its Q4 FY25 results on Friday, reporting a 6% year-on-year increase in revenue. The Gurugram-based firm also reported a profit of Rs 72 crore during the same period. Delhivery’s revenue from operations grew to Rs 2,191 crore in Q4 FY25, according to its financial statements filed with the National Stock Exchange (NSE). For the full fiscal year (FY25), Delhivery’s operating revenue increased 10% to Rs 8,932 crore in FY25 from Rs 8,141 crore in FY24. Delhivery's primary revenue sources were its logistics services, including warehousing, last-mile logistics, and designing and deploying logistics management systems. The firm also earned Rs 112 crore from non-operating activities, bringing its total revenue to Rs 2,303 crore in Q4 FY25. Meanwhile, for the full fiscal year, total income reached Rs 9,372 crore. For Delhivery, freight handling and servicing costs made up 70% of its total expenditure, rising by 3% to Rs 1,566 crore in Q4 FY25. Employee benefit expenses decreased by 6% to Rs 337 crore. Legal, depreciation, and other overhead costs contributed to a minor decrease in overall expenditure, which reached Rs 2,249 crore during the quarter. For the full financial year ending March 2025, the firm’s total expenses rose to Rs 9,217 crore as against Rs 8,825 crore in FY24. Delhivery's continued growth and controlled expenditure resulted in a profit of Rs 72 crore in Q4 FY25, compared to a loss of Rs 68 crore in Q4 FY24. On a fiscal basis, it turned profitable and reported a net profit of Rs 162 crore in FY25 as compared to a loss of Rs 249 crore in FY24. At the close of today’s trading session, Delhivery’s share price stood at Rs 321 per share, giving the company a market capitalization of Rs 23,957 crore.

Download the medial app to read full posts, comements and news.